Immunoblot (Line Blot) – IgM<<Return to Laboratory
Accredited by the Standards Council of Canada to Laboratory no. 594 - CAN-P-4E (ISO/IEC 17025)
Detection of IgM antibodies to purified recombinant proteins p39 and p41, in addition to a dimeric p25 (OspC) and VlsE of Borrelia by immunoblot assay.
- Lyme Disease
Fresh human serum. Minimum volume of serum required is 0.25 mL. Specimen should be collected during the acute phase (0-4 weeks) of onset of symptoms.
Collect blood in serum separator tubes.
Transfer an aliquot of serum to a 1.5 ml screw-top vial with O-ring (Sarstedt vial). Store specimens refrigerated up to 5 days or store frozen until shipped for testing. Ship frozen on dry or with freezer packs.
Shipping of specimens shall be done by a TDG certified individual in accordance with TDG regulations. For additional information regarding classification of specimens for the purposes of shipping, consult either Part 2 Appendix 3 of the TDG Regulations or section 3.6.2 of the IATA Dangerous Goods Regulations as applicable.
For additional guidance on the transport of infectious substances in other languages, please click on the link below.
Appropriate clinical symptoms with potential exposure to blacklegged ticks. Typical symptoms include fever, headache, fatigue, and a characteristic rash may be present. If left untreated, infection can spread to joints, the heart, and the nervous system.
The IgM Line blot is intended for use on human serum samples which have been found positive or equivocal by the ELISA procedure and negative by IgG Western blot in order to provide supportive evidence of infection with B. burgdorferi.
Completed Requisition for Serological Testing for Selected Zoonotic Agents. If possible, include the clinical history and lab results performed at local or provincial laboratories.
Specimens may be subject to rejection if they are not the appropriate sample type, have insufficient volume, or are not accompanied by relevant patient information. The IgM Line blot test will not be performed on serum samples either exceeding 4 weeks post onset of symptoms or if the IgG Western blot is positive. Please contact the laboratory if a re-infection is suspected.
Commercial Immunoblot (Line blot) assay. This is a qualitative test for the detection of IgM antibodies to individual proteins of B. burgdorferi. Caution must be used in supporting a diagnosis of B. burgdorferi infection when sera are positive by IgM immunoblot and negative by IgG Western blot after the initial 4 week period from onset of symptoms. If symptoms persist, a convalescent specimen should be submitted after an additional 3 to 6 weeks to test for seroconversion to IgG antibodies.
Initiation of antibiotic treatment prior to testing may result in decreased antibody production which will affect the outcome of serological testing. However, if Lyme disease is suspected based on clinical symptoms, treatment should be initiated.
21 calendar days.
- Moore A, Nelson C, Molins C, Mead P, & Schriefer M. 2016. Current Guidelines, Common Clinical Pitfalls, and Future Directions for Laboratory Diagnosis of Lyme Disease, United States. Emerging Infectious Diseases 22(7): 1169-1177.